Author Correction: FGL2 promotes tumor progression in the CNS by suppressing CD103+ dendritic cell differentiation

The original version of this Article contained errors in the author affiliations. Qingnan Zhao, Xueqing Xia, Longfei Huo and Shulin Li were incorrectly associated with Beijing Institute for Brain Disorders, 100069, Beijing, China.This has now been corrected in both the PDF and HTML versions of the A...

Full description

Bibliographic Details
Main Authors:	Jun Yan, Qingnan Zhao, Konrad Gabrusiewicz, Ling-Yuan Kong, Xueqing Xia, Jian Wang, Martina Ott, Jingda Xu, R. Eric Davis, Longfei Huo, Ganesh Rao, Shao-Cong Sun, Stephanie S. Watowich, Amy B. Heimberger, Shulin Li
Format:	Article
Language:	English
Published:	Nature Publishing Group 2019-02-01
Series:	Nature Communications
Online Access:	https://doi.org/10.1038/s41467-019-08770-5

id	doaj-356a0bf00a73476186ba34ce68950918
record_format	Article
spelling	doaj-356a0bf00a73476186ba34ce689509182021-05-11T12:11:26ZengNature Publishing GroupNature Communications2041-17232019-02-011011110.1038/s41467-019-08770-5Author Correction: FGL2 promotes tumor progression in the CNS by suppressing CD103+ dendritic cell differentiationJun Yan0Qingnan Zhao1Konrad Gabrusiewicz2Ling-Yuan Kong3Xueqing Xia4Jian Wang5Martina Ott6Jingda Xu7R. Eric Davis8Longfei Huo9Ganesh Rao10Shao-Cong Sun11Stephanie S. Watowich12Amy B. Heimberger13Shulin Li14Center for Brain Disorders Research, Capital Medical UniversityDepartment of Pediatrics–Research, The University of Texas MD Anderson Cancer CenterDepartment of Neurosurgery, The University of Texas MD Anderson Cancer CenterDepartment of Neurosurgery, The University of Texas MD Anderson Cancer CenterDepartment of Pediatrics–Research, The University of Texas MD Anderson Cancer CenterDepartment of Biostatistics, The University of Texas MD Anderson Cancer CenterDepartment of Neurosurgery, The University of Texas MD Anderson Cancer CenterDepartment of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer CenterDepartment of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer CenterDepartment of Pediatrics–Research, The University of Texas MD Anderson Cancer CenterDepartment of Neurosurgery, The University of Texas MD Anderson Cancer CenterDepartment of Immunology, The University of Texas MD Anderson Cancer CenterDepartment of Immunology, The University of Texas MD Anderson Cancer CenterDepartment of Neurosurgery, The University of Texas MD Anderson Cancer CenterDepartment of Pediatrics–Research, The University of Texas MD Anderson Cancer CenterThe original version of this Article contained errors in the author affiliations. Qingnan Zhao, Xueqing Xia, Longfei Huo and Shulin Li were incorrectly associated with Beijing Institute for Brain Disorders, 100069, Beijing, China.This has now been corrected in both the PDF and HTML versions of the Article.https://doi.org/10.1038/s41467-019-08770-5
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	Jun Yan Qingnan Zhao Konrad Gabrusiewicz Ling-Yuan Kong Xueqing Xia Jian Wang Martina Ott Jingda Xu R. Eric Davis Longfei Huo Ganesh Rao Shao-Cong Sun Stephanie S. Watowich Amy B. Heimberger Shulin Li
spellingShingle	Jun Yan Qingnan Zhao Konrad Gabrusiewicz Ling-Yuan Kong Xueqing Xia Jian Wang Martina Ott Jingda Xu R. Eric Davis Longfei Huo Ganesh Rao Shao-Cong Sun Stephanie S. Watowich Amy B. Heimberger Shulin Li Author Correction: FGL2 promotes tumor progression in the CNS by suppressing CD103+ dendritic cell differentiation Nature Communications
author_facet	Jun Yan Qingnan Zhao Konrad Gabrusiewicz Ling-Yuan Kong Xueqing Xia Jian Wang Martina Ott Jingda Xu R. Eric Davis Longfei Huo Ganesh Rao Shao-Cong Sun Stephanie S. Watowich Amy B. Heimberger Shulin Li
author_sort	Jun Yan
title	Author Correction: FGL2 promotes tumor progression in the CNS by suppressing CD103+ dendritic cell differentiation
title_short	Author Correction: FGL2 promotes tumor progression in the CNS by suppressing CD103+ dendritic cell differentiation
title_full	Author Correction: FGL2 promotes tumor progression in the CNS by suppressing CD103+ dendritic cell differentiation
title_fullStr	Author Correction: FGL2 promotes tumor progression in the CNS by suppressing CD103+ dendritic cell differentiation
title_full_unstemmed	Author Correction: FGL2 promotes tumor progression in the CNS by suppressing CD103+ dendritic cell differentiation
title_sort	author correction: fgl2 promotes tumor progression in the cns by suppressing cd103+ dendritic cell differentiation
publisher	Nature Publishing Group
series	Nature Communications
issn	2041-1723
publishDate	2019-02-01
description	The original version of this Article contained errors in the author affiliations. Qingnan Zhao, Xueqing Xia, Longfei Huo and Shulin Li were incorrectly associated with Beijing Institute for Brain Disorders, 100069, Beijing, China.This has now been corrected in both the PDF and HTML versions of the Article.
url	https://doi.org/10.1038/s41467-019-08770-5
work_keys_str_mv	AT junyan authorcorrectionfgl2promotestumorprogressioninthecnsbysuppressingcd103dendriticcelldifferentiation AT qingnanzhao authorcorrectionfgl2promotestumorprogressioninthecnsbysuppressingcd103dendriticcelldifferentiation AT konradgabrusiewicz authorcorrectionfgl2promotestumorprogressioninthecnsbysuppressingcd103dendriticcelldifferentiation AT lingyuankong authorcorrectionfgl2promotestumorprogressioninthecnsbysuppressingcd103dendriticcelldifferentiation AT xueqingxia authorcorrectionfgl2promotestumorprogressioninthecnsbysuppressingcd103dendriticcelldifferentiation AT jianwang authorcorrectionfgl2promotestumorprogressioninthecnsbysuppressingcd103dendriticcelldifferentiation AT martinaott authorcorrectionfgl2promotestumorprogressioninthecnsbysuppressingcd103dendriticcelldifferentiation AT jingdaxu authorcorrectionfgl2promotestumorprogressioninthecnsbysuppressingcd103dendriticcelldifferentiation AT rericdavis authorcorrectionfgl2promotestumorprogressioninthecnsbysuppressingcd103dendriticcelldifferentiation AT longfeihuo authorcorrectionfgl2promotestumorprogressioninthecnsbysuppressingcd103dendriticcelldifferentiation AT ganeshrao authorcorrectionfgl2promotestumorprogressioninthecnsbysuppressingcd103dendriticcelldifferentiation AT shaocongsun authorcorrectionfgl2promotestumorprogressioninthecnsbysuppressingcd103dendriticcelldifferentiation AT stephanieswatowich authorcorrectionfgl2promotestumorprogressioninthecnsbysuppressingcd103dendriticcelldifferentiation AT amybheimberger authorcorrectionfgl2promotestumorprogressioninthecnsbysuppressingcd103dendriticcelldifferentiation AT shulinli authorcorrectionfgl2promotestumorprogressioninthecnsbysuppressingcd103dendriticcelldifferentiation
_version_	1721445246112366592

Author Correction: FGL2 promotes tumor progression in the CNS by suppressing CD103+ dendritic cell differentiation

Similar Items